Where
Medicine Begins

COVID-19 Alert: Meridian is seeking participants for COVID-19 vaccine studies in Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), Nebraska (Grand Island, Norfolk, and Omaha), New York (Binghamton and Endwell), and South Dakota (Dakota Dunes). Read more >

Help improve lives.
Enjoy the experience.

Help move science forward

Clinical studies offer a way for almost anyone — regardless of their background — to help improve human health and wellbeing.

Get paid for participating

Most Meridian studies offer payment for time and travel. We'll let you know what to expect during your first phone call with Meridian.

Get early access to new medicines

Clinical studies offer more care options for patients suffering from common, unique, and rare health conditions.

+
Patients enrolled
+
Studies conducted
%
Enrollment for vaccine trials
+
Years in research

Talk to a Meridian enrollment specialist...

Midwest

Iowa, Nebraska, South Dakota

(402) 934-7563

Mon.-Fri., 8 a.m.-7 p.m.; Sat. 9 a.m.-Noon (CT)

South and East Coast

Georgia, Louisiana, Maryland, New York, Virginia

(912) 623-2240

Mon.-Th., 8 a.m.-7 p.m.; Fri., 8 a.m.-5 p.m. (ET)

Clients and partners

Meridian provides Phase I-IV research services for Sponsors and CROs developing drugs, medical devices, and diagnostics across numerous therapeutic areas.

Amgen, Abbvie, Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, Dermira, Genentech, GlaxcoSmithKline, Johnson and Johnson, Medicago, Merck, Moderna, Novartis, NovoNordisk, Pfizer, Regeneron. Sanofi Pasteur. Seqirus, Takeda